Literature DB >> 16340392

The ubiquity of memory retrieval deficits in patients with frontal-striatal dysfunction.

Vanessa S Zizak1, J Vincent Filoteo, Katherine L Possin, John A Lucas, Laurie M Rilling, Jennifer D Davis, Guerry Peavy, Andus Wong, David P Salmon.   

Abstract

OBJECTIVE AND
BACKGROUND: Previous studies have shown that patients with frontal-striatal dysfunction demonstrate improved performance on tests of recognition memory relative to free recall memory, suggesting deficits in retrieval processes. Not all studies, however, have indicated that all patients with frontal-striatal dysfunction display this profile. In this study, we examined the ubiquity of this "retrieval deficit" profile in a relatively large sample of patients with Parkinson disease (PD) or Huntington disease (HD).
METHODS: Participants included 150 patients with PD and 65 patients with HD. Patients were classified as demonstrating a retrieval deficit or not based on a comparison of their standardized performances on the Recognition Discriminability and Long-Delay Free Recall indices from the California Verbal Learning Test.
RESULTS: Results indicated that 1) a retrieval deficit was more prevalent in patients with HD than PD, 2) this group difference emerged only in patients with at least a mild level of global cognitive impairment, and 3) even when the profile did emerge more frequently in patients with HD, it was present in only 44% of the patients.
CONCLUSIONS: These findings suggest that not all patient groups with frontal-striatal dysfunction display a retrieval deficit profile, but in groups that do (ie, patients with HD), it is more likely to appear in individuals with greater cognitive impairment.

Entities:  

Mesh:

Year:  2005        PMID: 16340392     DOI: 10.1097/01.wnn.0000192134.53616.39

Source DB:  PubMed          Journal:  Cogn Behav Neurol        ISSN: 1543-3633            Impact factor:   1.600


  8 in total

1.  Episodic memory in dementia: Characteristics of new learning that differentiate Alzheimer's, Huntington's, and Parkinson's diseases.

Authors:  Eleni Aretouli; Jason Brandt
Journal:  Arch Clin Neuropsychol       Date:  2010-06-08       Impact factor: 2.813

2.  Antiretroviral adherence and the nature of HIV-associated verbal memory impairment.

Authors:  Matthew J Wright; Ellen Woo; Jessica Foley; Mark L Ettenhofer; Maria E Cottingham; Amanda L Gooding; Jiah Jang; Michelle S Kim; Steve A Castellon; Eric N Miller; Charles H Hinkin
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2011       Impact factor: 2.198

Review 3.  Progress in developing transgenic monkey model for Huntington's disease.

Authors:  Brooke R Snyder; Anthony W S Chan
Journal:  J Neural Transm (Vienna)       Date:  2017-11-10       Impact factor: 3.575

4.  Verbal learning and memory in patients with dementia with Lewy bodies or Parkinson's disease with dementia.

Authors:  J Vincent Filoteo; David P Salmon; Dawn M Schiehser; Amy E Kane; Joanne M Hamilton; Laurie M Rilling; John A Lucas; Vanessa Zizak; Douglas R Galasko
Journal:  J Clin Exp Neuropsychol       Date:  2009-02-17       Impact factor: 2.475

5.  Neuropsychological predictors of patient-reported cognitive decline after deep brain stimulation in Parkinson's disease.

Authors:  Kelly A Mills; Kristyn Donohue; Aathman Swaminathan; Jeannie-Marie Leoutsakos; Gwenn Smith; Jason Brandt
Journal:  J Clin Exp Neuropsychol       Date:  2018-10-08       Impact factor: 2.475

6.  Longitudinal transcriptomic dysregulation in the peripheral blood of transgenic Huntington's disease monkeys.

Authors:  Jannet Kocerha; Yuhong Liu; David Willoughby; Kumaravel Chidamparam; Joseph Benito; Kate Nelson; Yan Xu; Tim Chi; Heidi Engelhardt; Sean Moran; Shang-Hsun Yang; Shi-Hua Li; Xiao-Jiang Li; Katherine Larkin; Adam Neumann; Heather Banta; Jin Jing Yang; Anthony W S Chan
Journal:  BMC Neurosci       Date:  2013-08-17       Impact factor: 3.288

7.  Structural MRI Correlates of Episodic Memory Processes in Parkinson's Disease Without Mild Cognitive Impairment.

Authors:  Eva Pirogovsky-Turk; J Vincent Filoteo; Irene Litvan; Deborah L Harrington
Journal:  J Parkinsons Dis       Date:  2015       Impact factor: 5.568

8.  miR-196a Ameliorates Cytotoxicity and Cellular Phenotype in Transgenic Huntington's Disease Monkey Neural Cells.

Authors:  Tanut Kunkanjanawan; Richard L Carter; Melinda S Prucha; Jinjing Yang; Rangsun Parnpai; Anthony W S Chan
Journal:  PLoS One       Date:  2016-09-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.